Diagnostic performance of endobronchial ultrasound-guided mediastinal lymph node sampling in early stage non-small cell lung cancer: A prospective study.

Macarena R VialOisin J O'ConnellHoriana B GrosuMike HernandezLaila NoorRoberto F CasalJohn StewartMona SarkissCarlos A JimenezDavid RiceReza MehranDavid E OstGeorge A Eapen

Published in: Respirology (Carlton, Vic.) (2017)

A significant proportion of patients with N0/N1 disease by PET/CT had N2 disease (20%) and EBUS-TBNA identified a substantial fraction of these patients, thus improving diagnostic accuracy compared with PET/CT alone. Sensitivity of EBUS-TBNA however appears lower compared with historical data from patients with larger volume mediastinal disease. Therefore, strategies to improve EBUS-TBNA accuracy in this population should be further explored.

Keyphrases

pet ct
lymph node
ultrasound guided
early stage
positron emission tomography
end stage renal disease
newly diagnosed
ejection fraction
sentinel lymph node
prognostic factors
big data
electronic health record
neoadjuvant chemotherapy
deep learning
data analysis